Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: a systematic review

William Phillips*, Zak Thornton, Lily Andrews, Richard S Daly, Julian P T Higgins, Philippa Davies, Kathreena M Kurian

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

Original languageEnglish
Article number104288
JournalCritical Reviews in Oncology - Hematology
Volume196
Early online date6 Feb 2024
DOIs
Publication statusPublished - 2024

Bibliographical note

Funding Information:
ZAT is funded by Southmead Hospital Charitable Funds : Brain tumour bank and research fund 8036 . LJA and KMK are funded by Cancer Research UK (grant number C30758/A29791 ). KMK is funded by Innovate [grant number 10027624 ] PD is funded by Cancer Research UK (grant number C18281/A29019 ) JPTH is a National Institute for Health and Care Research ( NIHR ) Senior Investigator ( NIHR203807 ). The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care .

Publisher Copyright:
© 2024 The Authors

Structured keywords

  • ICEP

Cite this